This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Swine flu outbreak in 2009

Authoring team

  • human cases of swine-origin influenza A (H1N1) virus (S-OIV) infection have been confirmed in the U.S. and Mexico with new cases emerging from countries like Canada, Austria, Germany, Israel, Spain, Switzerland and the United Kingdom (1)

  • the virus that has been documented is a novel influenza virus strain that has not been previously found in the world (2). It is antigenically different from the human H1N1 virus (2) and contains genes from swine, avian and human influenza viruses (3)

  • transmission is similar to normal seasonal influenza:
    • from person to person - through infected air droplets
    • indirectly - when a respiratory-droplet contaminated objects are touched

  • currently there is insufficient information available to determine the clinical complications of the disease or the risk groups for complications. But deaths due to severe respiratory disease have been reported (4)

  • clinicians should consider both the complications and the risk groups for complications to be comparable to seasonal influenza (5). Although the extent of the disease in children is unknown, from seasonal influenza and past pandemics it is evident that young children (particularly younger than 5 years of age) are at a higher risk of influenza-related complications (6).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.